Chinmaya Rath - 23 Mar 2023 Form 3 Insider Report for GLYCOMIMETICS INC (GLYC)

Reporting relationship: SVP and Chief Business Officer
Issuer ticker: GLYC
Reported as of: 23 Mar 2023
Net transaction value: $0
SEC form: 3
Accepted by SEC: 31 Mar 2023, 16:36:25 UTC
Next SEC filing: 17 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ Brian F. Leaf, as attorney-in-fact

Key filing fact

Chinmaya Rath filed Form 3 for GLYCOMIMETICS INC (GLYC) on 31 Mar 2023.

Key facts

This page summarizes Chinmaya Rath's Form 3 filing for GLYCOMIMETICS INC (GLYC).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 31 Mar 2023, 16:36.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GLYC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 161,178
Date: 23 Mar 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GLYC holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 23 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 150,000
Exercise price: $3.48
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares underlying this option will vest on February 10, 2024 and the remaining shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date.